Home LiteratureArticle Details
PMID: 10501219 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.

Journal of neurochemistry ·Vol. 73 ·No. 4 ·1999-10-00 ·Pages 1711-7

Herrick-Davis K, Grinde E, Niswender CM

Abstract

Rat and human serotonin 5-HT2C receptor isoforms were evaluated for agonist-independent activation of inositol phosphate production in COS-7 cells. The nonedited isoform (5-HT(2C-INI)) displayed the greatest basal activity, stimulating inositol phosphate production fourfold over the fully edited isoform (5-HT(2C--VGV)). All of the other isoforms tested displayed intermediate levels of basal activity. Decreasing receptor expression levels by 50% produced a parallel decrease in basal activity. 5-HT stimulated inositol phosphate production twofold over basal levels through the 5-HT(2C-INI) receptor and eightfold over basal levels through the 5-HT(2C-VGV) receptor but produced similar maximal levels of inositol phosphate. 5-HT competition for [3H]mesulergine binding to 5-HT(2C-INI) best fit a two-site analysis with K(H) = 7.6 nM and K(L) = 160 nM, whereas 5-HT(2C-VGV) best fit a one-site model with Ki = 163 nM. [3H]5-HT labeled 36% of the total population of 5-HT(2C-INI) receptors labeled by [3H]mesulergine but only 12% of 5-HT(2C-VGV) receptors. [H]5-HT K(D) values increased from 5.1 nM for 5-HT(2C-INI) to 20 nM for 5-HT(2C-VGV). [3H]Mesulergine K(D) values were the same for both isoforms. 5-HT EC50 values for inositol phosphate production increased from 6.1 nM for 5-HT(2C-INI) to 30 nM for 5-HT(2C-VGV). These results demonstrate that RNA editing decreases 5-HT2C receptor basal activity, agonist affinity, and potency, indicating that RNA editing may play a role in regulating serotonergic signal transduction and response to drug therapy.

MeSH Terms
Animals COS Cells Ergolines/pharmacokinetics Humans Inositol Phosphates/metabolism Kinetics Mianserin/pharmacology Mutagenesis, Site-Directed Pargyline/pharmacology RNA Editing Rats Receptor, Serotonin, 5-HT2C Receptors, Serotonin/genetics,physiology Recombinant Proteins/metabolism Serotonin/metabolism Serotonin Antagonists/pharmacokinetics Signal Transduction Transfection
Chemicals
Ergolines Inositol Phosphates Receptor, Serotonin, 5-HT2C Receptors, Serotonin Recombinant Proteins Serotonin Antagonists Mianserin Serotonin Pargyline mesulergine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Herrick-Davis K
Department of Pharmacology and Neuroscience, Albany Medical College, New York 12208, USA.
Grinde E
Niswender C M
Article Info
Journal
Journal of neurochemistry
Abbr.
J Neurochem
ISSN
0022-3042
Published
1999-10-00
Pages
1711-7
Language
English
Region
England
NLM ID
2985190R
Subset
IM
Grants
NIMH NIH HHS · MH34007 · United States
NIMH NIH HHS · MH57019 · United States
NINDS NIH HHS · NS35891 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com